Prognostic significance of proliferative and apoptotic fractions in low grade follicle center cell‐derived non‐Hodgkin's lymphomas

The biologic parameters, DNA ploidy and proliferative activity, have been suggested as prognostic factors in non‐Hodgkin's lymphoma (NHL). However, reports on the prognostic importance of these factors in follicle center cell‐derived (FCC) centroblastic/centrocytic (CB/CC) NHL patients with long follow‐up are scarce.

[1]  H Stein,et al.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.

[2]  B. Coiffier,et al.  Is the International Prognostic Index for Aggressive Lymphoma patients useful for follicular lymphoma patients? , 1994, Journal of Clinical Oncology.

[3]  A. López-Guillermo,et al.  Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  M. Melamed,et al.  Detection of apoptosis-associated DNA strand breaks in fine-needle aspiration biopsies by in situ end labeling of fragmented DNA. , 1994, Cytometry.

[5]  G. Evan,et al.  Oncogenes and cell death. , 1994, Current opinion in genetics & development.

[6]  W. Bursch,et al.  Apoptosis is induced by transforming growth factor‐β1 within 5 hours in regressing liver without significant fragmentation of the DNA , 1993, Hepatology.

[7]  Emili Montserrat,et al.  A predictive model for aggressive non-Hodgkin's lymphoma. , 1993, The New England journal of medicine.

[8]  P. Walker,et al.  Role of proteolysis in apoptosis: involvement of serine proteases in internucleosomal DNA fragmentation in immature thymocytes. , 1993, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[9]  J. Hickman,et al.  Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. , 1993, The EMBO journal.

[10]  R. Braylan.  Flow-cytometric DNA analysis in the diagnosis and prognosis of lymphoma. , 1993, American journal of clinical pathology.

[11]  B. Nathwani,et al.  Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  S. Pileri,et al.  Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. , 1993, The American journal of pathology.

[13]  John Calvin Reed,et al.  Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. , 1993, Blood.

[14]  Johannes Gerdes,et al.  Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections , 1992, The Journal of pathology.

[15]  S. Ben‐Sasson,et al.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.

[16]  John Calvin Reed,et al.  bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. , 1992, Cancer research.

[17]  X. M. Sun,et al.  Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. , 1992, The Biochemical journal.

[18]  S. Korsmeyer.  Bcl-2 initiates a new category of oncogenes: regulators of cell death. , 1992, Blood.

[19]  A. Zetterberg,et al.  The prognostic significance of nuclear dna content in prostatic carcinoma , 1992, Cancer.

[20]  Ryan C. Leonard,et al.  Original article: The identification of discrete prognostic groups in low grade non-Hodgkin's lymphoma , 1991 .

[21]  J. Cleveland,et al.  Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. , 1991, Oncogene.

[22]  W. Velasquez,et al.  Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  J. Macartney,et al.  Reduced apoptotic cell death in follicular lymphoma , 1991, The Journal of pathology.

[24]  R. Camplejohn,et al.  DNA flow cytometry of follicular non-Hodgkin's lymphoma. , 1991, Journal of clinical pathology.

[25]  P. Barbini,et al.  Diffuse centrocytic and/or centroblastic malignant non‐hodgkin's lymphomas: Comparison of mitotic and pyknotic (apoptotic) indices , 1991, International journal of cancer.

[26]  Y. Sato,et al.  Determination of proliferative fractions detected by immunohistochemistry with the monoclonal antibodies to bromodeoxyuridine and Ki‐67 in malignant lymphomas , 1989, Hematological oncology.

[27]  C C Bird,et al.  Prognostic indicators in centroblastic-centrocytic lymphoma. , 1988, Journal of clinical pathology.

[28]  T. Grogan,et al.  Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67 , 1988 .

[29]  T. Lister,et al.  The prognostic value of Ki67 immunostaining in non‐Hodgkin's lymphoma , 1988, The Journal of pathology.

[30]  D. Jones,et al.  A comparison of three methods for the determination of the growth fraction in non-Hodgkin's lymphoma. , 1987, British Journal of Cancer.

[31]  P. Biberfeld,et al.  Cell proliferation and DNA content in non‐hodgkin' s lymphoma: Flow cytometry in relation to lymphoma classification , 1986, Cancer.

[32]  Y. Tsujimoto,et al.  Involvement of the bcl-2 gene in human follicular lymphoma. , 1985, Science.

[33]  G. Auer,et al.  The prognostic significance of DNA measurements in endometrial carcinoma. , 1984, Cytometry.

[34]  T. Caspersson,et al.  DNA content and survival in mammary carcinoma. , 1980, Analytical and quantitative cytology.

[35]  W. Göhde,et al.  Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle , 1975, Radiation and environmental biophysics.

[36]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[37]  A. Porwit,et al.  DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[38]  D. Harrison,et al.  Apoptosis: molecular aspects and pathological perspective , 1994 .

[39]  S. J. Horning.  Low-grade lymphoma 1993: state of the art. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[40]  E. Kimby,et al.  Chlorambucil/prednisone vs. CHOP in symptomatic low-grade non-Hodgkin's lymphomas: a randomized trial from the Lymphoma Group of Central Sweden. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[41]  V. Morrison,et al.  Combination chemotherapy in the treatment of follicular low-grade lymphoma. , 1993, Leukemia & lymphoma.

[42]  M. Andreeff,et al.  Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathology. , 1993, Cytometry.

[43]  A. Eastman,et al.  The origins of DNA breaks: a consequence of DNA damage, DNA repair, or apoptosis? , 1992, Cancer investigation.

[44]  B. Glimelius,et al.  Prognostic significance of flow cytometry studies in B‐cell non‐hodgkin lymphoma , 1990, Hematological oncology.

[45]  F. Rilke,et al.  Comparative analysis of [3H]‐thymidine labelling index and monoclonal antibody Ki‐67 in non‐Hodgkin's lymphomas , 1988, Hematological oncology.

[46]  C. Potten.  Perspectives on mammalian cell death. , 1987 .